These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 33935967)
1. Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis. Zhang H; Li Y; Yuan L; Yao L; Yang J; Xia L; Shen H; Lu J Front Endocrinol (Lausanne); 2021; 12():642676. PubMed ID: 33935967 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1. Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863 [TBL] [Abstract][Full Text] [Related]
3. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells. Pengjam Y; Madhyastha H; Madhyastha R; Yamaguchi Y; Nakajima Y; Maruyama M Phytomedicine; 2016 Apr; 23(4):417-28. PubMed ID: 27002412 [TBL] [Abstract][Full Text] [Related]
4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
5. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. Song C; Yang X; Lei Y; Zhang Z; Smith W; Yan J; Kong L J Cell Physiol; 2019 Jul; 234(7):11969-11975. PubMed ID: 30515780 [TBL] [Abstract][Full Text] [Related]
7. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα. Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211 [TBL] [Abstract][Full Text] [Related]
8. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis. Gong W; Dou H; Liu X; Sun L; Hou Y Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134 [TBL] [Abstract][Full Text] [Related]
9. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. Xing R; Zhang Y; Li C; Sun L; Yang L; Zhao J; Liu X Int J Mol Med; 2016 Oct; 38(4):1125-34. PubMed ID: 27599586 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 26 suppresses receptor activator of nuclear factor κB ligand induced osteoclastogenesis via down-regulation of nuclear factor of activated T-cells, cytoplasmic 1 and nuclear factor κB activity. Peng YJ; Wang CY; Lin YH; Lin GJ; Huang SH; Shyu JF; Sytwu HK; Cheng CP Rheumatology (Oxford); 2016 Nov; 55(11):2074-2083. PubMed ID: 27550297 [TBL] [Abstract][Full Text] [Related]
12. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim HR; Kim BM; Cho ML; Lee SH Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways. Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353 [TBL] [Abstract][Full Text] [Related]
14. Obacunone inhibits RANKL/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling. Hu H; Wang X; Huang Y; He B; Zhu J; Sun K; Deng C; Guo Y; Hao D; Jian B Cytokine; 2023 Apr; 164():156134. PubMed ID: 36804257 [TBL] [Abstract][Full Text] [Related]
15. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway. Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460 [TBL] [Abstract][Full Text] [Related]
16. Effects of IL-34 and anti-IL-34 neutralizing mAb on alveolar bone loss in a ligature-induced model of periodontitis. Duarte C; Yamada C; Ngala B; Garcia C; Akkaoui J; Birsa M; Ho A; Nusbaum A; AlQallaf H; John V; Movila A Mol Oral Microbiol; 2024 Jun; 39(3):93-102. PubMed ID: 37902168 [TBL] [Abstract][Full Text] [Related]
17. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca Cao B; Dai X; Wang W J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123 [TBL] [Abstract][Full Text] [Related]
19. Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice. Huang J; Yin H; Rao SS; Xie PL; Cao X; Rao T; Liu SY; Wang ZX; Cao J; Hu Y; Zhang Y; Luo J; Tan YJ; Liu ZZ; Wu B; Hu XK; Chen TH; Chen CY; Xie H Theranostics; 2018; 8(9):2435-2446. PubMed ID: 29721090 [TBL] [Abstract][Full Text] [Related]
20. Quercetin, a Plant Polyphenol, Has Potential for the Prevention of Bone Destruction in Rheumatoid Arthritis. Kim HR; Kim BM; Won JY; Lee KA; Ko HM; Kang YS; Lee SH; Kim KW J Med Food; 2019 Feb; 22(2):152-161. PubMed ID: 30596535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]